Ironwood Pharmaceuticals, Inc. (FRA:I76)
3.200
0.00 (0.00%)
At close: Dec 4, 2025
Ironwood Pharmaceuticals Revenue
Ironwood Pharmaceuticals had revenue of $122.06M USD in the quarter ending September 30, 2025, with 33.26% growth. This brings the company's revenue in the last twelve months to $338.99M, down -10.42% year-over-year. In the year 2024, Ironwood Pharmaceuticals had annual revenue of $351.41M, down -20.63%.
Revenue (ttm)
$338.99M
Revenue Growth
-10.42%
P/S Ratio
1.68
Revenue / Employee
$1.34M
Employees
253
Market Cap
486.64M EUR
Revenue Chart
* This company reports financials in USD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 351.41M | -91.33M | -20.63% |
| Dec 31, 2023 | 442.74M | 32.14M | 7.83% |
| Dec 31, 2022 | 410.60M | -3.16M | -0.76% |
| Dec 31, 2021 | 413.75M | 24.23M | 6.22% |
| Dec 31, 2020 | 389.52M | -38.89M | -9.08% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| SAP SE | 36.49B |
| Siemens Aktiengesellschaft | 78.91B |
| Allianz SE | 105.02B |
| Deutsche Telekom AG | 121.02B |
| Siemens Energy AG | 39.08B |
| Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 62.10B |
| Rheinmetall AG | 11.00B |
| Deutsche Bank Aktiengesellschaft | 29.86B |